 salvag therapi high-dos chemotherapi autolog bone marrow support treatment primari nonseminomat mediastin germ cell tumor author experi use high-dos chemotherapi autolog bone marrow rescu abmr salvag therapi treatment patient recurr refractori primari nonseminomat mediastin germ cell tumor pmgct author patient pmgct high-dos carboplatin patient ifosfamid abmr patient second relaps cisplatin refractori progress week last cisplatin median prior chemotherapi regimen rang prior cisplatin therapi ifosfamide-bas therapi patient cisplatin refractori partial respons PR short durat patient round therapi patient cours remaind round therapi inadequ respons patient excess toxic patient patient peritranspl period due patient patient median surviv group day rang day day patient complet remiss partial remiss stabl diseas progress diseas use high-dos carboplatin etoposid ifosfamid abmr effect treatment group patient pmgct second relaps cisplatin refractori